Multidisciplinary Management of Drug Shortages and Associated Ethical Dilemmas
Back to course
Asset Caption
"This article was first published in the Spring 2024 issue of Critical Connections.
Drug shortages have posed significant patient safety issues in the past, including during the COVID-19 pandemic as shortages affected immunomodulators (e.g., tocilizumab), antivirals (e.g., remdesivir), sedatives, and opioid analgesics. Creating a multidisciplinary drug shortages committee to monitor and make rapid evidence-based decisions during drug shortages is essential for every hospital and healthcare system.
Critical Connections, the critical care industry’s only newsmagazine, provides information on cutting-edge topics in critical care useful to the entire multiprofessional team."